Search
Login
Register
Menu
BJMO
Home
News
CongressUpdate
Specials
Links
About
Last issue
All issues
Newsletters
Subscribe
Table of Contents:
Avoiding ‘whoops’ surgery in primary bone tumours in the spine: An intake protocol for all possibly involved caregivers in a tertiary hospital
Real-world evidence for implementation of new drugs
What are the treatment options for metastatic castration-resistant prostate cancer anno 2023?
Audits in medical oncology
Cyclophosphamide-induced hyponatremia leading to status epilepticus in a breast cancer patient
Patient selection strategies throughout the renal cell carcinoma disease spectrum
New oncology reimbursements in Belgium
Read online
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Journal issues
>
Recent Highlights In Targeted Therapy Special, November 2021
Recent Highlights In Targeted Therapy Special, November 2021
Recent Highlights In Targeted Therapy Special, November 2021
Previous issue
Next issue
All issues
Subscribe
Interactive PDF
Quickly to
REVIEW ONCOLOGY
PRACTICE GUIDELINES
PHARMACOTHERAPY
RESEARCH
ONCOCASE
ONCOTHESIS
CONGRESS NEWS
REIMBURSEMENT NEWS
Index
SPECIAL
Optimising the first-line treatment of patients with ROS1-rearranged non-small cell lung cancer
T. Feys
PARP inhibition as a new treatment modality in metastatic prostate cancer
T. Feys
Targeting RET-alterations in solid tumours
J. Blokken, T. Feys
Treatment sequencing in patients with advanced, BRAF-mutant melanoma
T. Feys, J. Blokken
Targeted therapy making its move in early-stage EGFR-mutant NSCLC
J. Blokken, T. Feys
The role of HER2-targeted therapy in metastatic gastrointestinal cancer: gastric cancer (and beyond)
T. Feys
Events
Current Month
january, 2023
Evenementen
All
Patient
Specialist
X